The glomerular filtration barrier consists of fenestrated capillary endothelium, basement membrane, and visceral epithelial cells (podocytes) connected by slit diaphragms. The barrier is selectively permeable based on size (proteins >60 kDa filtered poorly) and charge (negative charge repels anionic proteins). Proteinuria results from glomerular permselectivity loss (from podocyte injury or slit diaphragm disruption), increased filtration pressure, or plasma protein overload. Selective proteinuria (mainly albumin) indicates podocyte disease; non-selective proteinuria suggests basement membrane damage.
Understand the size and charge barriers to protein filtration. Study podocyte foot process effacement on electron microscopy as the structural correlate of proteinuria. Differentiate selective proteinuria (nephrotic syndrome from podocyte disease) from non-selective proteinuria (crescentic GN from immune complex deposition).
Proteinuria is not always pathologic; orthostatic proteinuria occurs only when upright and is benign. Proteinuria alone does not indicate glomerular disease; tubular disease can cause proteinuria from reabsorption failure, though usually mild. Heavy proteinuria (>3 g/day) is typically glomerular in origin.
From your study of renal physiology and filtration, you know that the glomerulus filters approximately 180 liters of plasma per day, and that this filtration is highly selective — small solutes and water cross freely while cells and proteins are largely retained in the circulation. What makes this discrimination possible is not a single membrane but a three-layer filtration barrier, each layer contributing a distinct mechanism of exclusion, and their failure at any layer produces proteinuria.
The first layer is the fenestrated capillary endothelium: unlike most capillaries, glomerular capillaries have large fenestrae (pores 60–80 nm wide) that allow free passage of plasma. However, the endothelial surface is coated with a glycocalyx — a negatively charged layer of glycoproteins and proteoglycans — that repels anionic proteins including albumin. The second layer is the glomerular basement membrane (GBM), a condensed sheet of type IV collagen, laminin, and heparan sulfate proteoglycans. The heparan sulfate carries a strongly negative charge, providing a second electrochemical barrier against anionic proteins. The GBM also functions as a mechanical size filter, restricting passage of proteins above roughly 60 kDa. The third and most critical layer consists of podocytes — highly specialized visceral epithelial cells that wrap their interdigitating foot processes around the outside of capillaries. Between adjacent foot processes runs the slit diaphragm, a molecular mesh composed of nephrin and podocin proteins. The slit diaphragm is the final and most selective barrier; its effective pore size determines which proteins can enter the tubular filtrate.
Proteinuria results from failure of one or more barrier components, and the character of the proteinuria points to which layer is damaged. Selective proteinuria — predominantly albumin — indicates isolated disruption of the slit diaphragm or podocyte foot processes while the GBM remains intact. Minimal change disease, the classic cause of nephrotic syndrome in children, demonstrates this: light microscopy shows a nearly normal glomerulus, but electron microscopy reveals foot process effacement — the foot processes retract and fuse into a continuous sheet, eliminating the slit diaphragms. Without the slit diaphragm, the charge and size barriers provided by the endothelium and GBM are insufficient to retain albumin, and massive proteinuria results. Non-selective proteinuria — loss of both albumin and larger proteins like IgG — indicates GBM disruption, as seen in membranous nephropathy or crescentic glomerulonephritis. When the GBM itself is damaged, even proteins too large to pass an intact barrier escape into the filtrate.
The consequences of proteinuria extend beyond what is lost in the urine. As plasma oncotic pressure falls (from albumin depletion), the Starling forces that keep fluid in capillaries are disrupted, driving edema into tissues. Simultaneously, the liver upregulates lipoprotein synthesis in response to reduced oncotic pressure, producing hyperlipidemia. The complete nephrotic syndrome — heavy proteinuria (>3.5 g/day), hypoalbuminemia, edema, and hyperlipidemia — illustrates how a structural lesion at the filtration barrier propagates into a systemic clinical syndrome through the downstream effects of protein loss. Recognizing proteinuria as selective versus non-selective, and heavy versus mild, is therefore the first step in localizing the anatomical site of barrier failure and generating a differential diagnosis for glomerular disease.